|
Brevibloc Double Strength In Plastic ContainerDrug - Brevibloc Double Strength In Plastic Container The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Esmolol Hydrochloride
Strength -
2GM/100ML
Applicant -
BAXTER HLTHCARE CORP
New Drug Application (NDA) Number -
019386
Product Number -
005
Therapeutic Equivalence (TE) Code -
Approval Date -
Jan 27, 2003
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Baxter Healthcare Corp Anesthesia Critical Care
Brevibloc Double Strength In Plastic Container
Brevibloc 250mg/ml Injectable; Injection
Brevibloc Double Strength In Plastic Container 2gm/100ml Injectable; Injection Wyamycin S Eq 500mg Base Tablet; Oral Lexapro Eq 5mg Base/5ml Solution; Oral Lexapro 10mg Tablet; Oral Lexapro 20mg Tablet; Oral Lexapro 5mg Tablet; Oral Brevibloc 100mg/ml Injectable; Injection Brevibloc 10mg/ml Injectable; Injection Brevibloc 20mg/ml Injectable; Injection NewDrugInformation |